Manalapan, NJ, United States of America

Sanjeev Kumar

This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2008-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjeev Kumar. Retrieved from https://idiyas.com/inventor/sanjeev-kumar-829obp44

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sanjeev Kumar: A Pioneer in Cannabinoid Research

Introduction

Sanjeev Kumar, an inventive scientist based in Manalapan, NJ, has made significant contributions to medical science through his pioneering work in cannabinoid research. With a total of two patents to his name, Kumar is recognized for developing novel compounds that hold promise in treating a variety of debilitating conditions.

Latest Patents

Kumar's latest inventions focus on substituted amides, which are novel compounds that act as antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor. These compounds demonstrate potential for therapeutic use in treating, preventing, and suppressing diseases mediated by the CB1 receptor. Notably, they can be harnessed as centrally acting drugs for conditions such as psychosis, cognitive disorders, anxiety, movement disorders, and schizophrenia. Additionally, these compounds show promise in addressing substance abuse disorders, obesity, asthma, and other significant health issues.

Career Highlights

Kumar works at Merck & Company, Inc., where he has been instrumental in advancing research related to cannabinoid compounds. His work is not only academically impactful but also aligns with the company's objective to develop innovative treatments for complex diseases. Kumar's extensive research emphasizes the importance of understanding cannabinoid interactions and their potential therapeutic benefits.

Collaborations

In his professional journey, Sanjeev Kumar has collaborated with esteemed colleagues, including Linus S Lin and William K Hagmann. Their teamwork has facilitated the exploration of cannabinoid applications and the development of new pharmaceuticals aimed at improving patient outcomes across a variety of neurological and psychological conditions.

Conclusion

Sanjeev Kumar represents a dedicated inventor committed to pushing the boundaries of cannabinoid research. His innovative work at Merck & Company, Inc. and the development of significant patents reflect his contribution to the medical field. As research progresses, Kumar's inventions hold the potential to revolutionize treatment approaches for several critical health challenges, reinforcing the essential role of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…